GSK Plc Profit Margin

The latest profit margin for GSK is 5.11% as of June 2026. That compares with 10.0% in the prior-year period — down 48.9% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside GSK Plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, GSK's profit margin moved from 10.0% to 5.11% — a 48.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in GSK Plc's valuation or profitability profile.

Against Healthcare companies, GSK currently prints 5.11% for profit margin, while the sector average sits near 13.89%. That is roughly 63.2% below the sector mean. Large gaps often invite a closer look at GSK Plc's growth, margins, and balance sheet.

Profit Margin shows how effectively GSK Plc converts resources into returns. At 5.11%, GSK may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 10.0% in the prior-year period — down 48.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting GSK's profit margin (5.11%), review year-over-year change from 10.0%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.